Applied UV

Applied UV, Inc. engages the development, acquisition and commercialization of technology that addresses air purification and infection control in the healthcare, hospitality, commercial, municipal, and residential markets. It operates through following segments: Disinfection, Hospitality, and Corporate. The Disinfection segment designs, manufactures, assembles, and distributes automated disinfecting mirror systems for use in hospitals and other healthcare facilities. The Hospitality segment manufactures fine mirrors specifically for the hospitality industry. The Corporate segment represents expenses primarily related to corporate governance, such as board fees, legal expenses, audit fees, executive management, and listing costs. The company was founded on February 26, 2019 and is headquartered in Mount Vernon, NY.

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Applied UV Inc (NASDAQ: AUVI) has appointed James Alecxih as Chief Executive Officer and as a member of the company's board, effective December 8, 2021. Alecxih's appointment follows the resignation of Keyoumars Saeed, who served as CEO since June 30, 2020.

Applied UV Appoints James Alecxih As CEO

Highly Accomplished Executive with Proven Track Record of Leading Healthcare Businesses Q Saeed to transition to consultant to the Company MOUNT VERNON, NY / ACCESSWIRE / December 9, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an industry leader in air and surface pathogen elimination technology today announced that its Board of Directors has appointed James Alecxih as Chief Executive Officer and as a member of the Company's Board of Directors, effective December 8, 2021. Mr. Alecxih's appointment follows the resignation of Keyoumars ("Q") Saeed, who served as Chief Executive Officer since June 30, 2020, prior to the Company's initial public offering ("IPO") on August 31, 2020.

Applied UV Announces the Appointment of James Alecxih as Chief Executive Officer

The stock price of Applied UV Inc (NASDAQ: AUVI) increased by over 5% during intraday trading. This is why it happened.

Applied UV (AUVI) Stock: Why The Price Increased Today

Applied U.V., Inc. (NASDAQ:AUVI) is a pathogen elimination tech firm that uses the power of narrow-range U.V.

Applied U.V. To Install Airocide at AFRMIS in Thailand

AFRIMS to install Airocide® technology to protect visitors and staff AFRIMS is a biomedical research facility of the U.S. Army's Walter Reed Army Institute of Research MOUNT VERNON, NY / ACCESSWIRE / December 1, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that its exclusive distribution partner in Thailandwill be installing Airocide® units at the Armed Forces Research Institute of Medical Sciences ("AFRIMS"), Bangkok, Thailand, to help create safer and cleaner environments for visitors and staff. AFRIMS is a biomedical research facility of the U.S. Army's Walter Reed Army Institute of Research ("WRAIR").

Applied UV Continues Global Expansion with Airocide(R) Installations in Thailand at the Acclaimed Armed Forces Research Institute of Medical Sciences ("AFRIMS")

The stock price of Applied UV Inc (NASDAQ: AUVI) increased by over 14% during intraday trading today. This is why it happened.

Applied UV (AUVI) Stock; Why The Price Jumped Today

Applied UV, Inc. (AUVI) CEO Keyo Saeed on Q3 2021 Results - Earnings Call Transcript

Results: Revenue increased 88.5% to $3.55 million as compared to $1.88 in the previous quarter Gross profit increased to $1.0 million, or 29.6% vs. sales as compared to $0.5m, or 28.3% vs.

Applied UV Reports Third Quarter 2021 Results

MOUNT VERNON, NY / ACCESSWIRE / November 11, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that the Company will be hosting an investor conference call and live webcast on Tuesday, November 16, 2021 at 9:00 am ET to review its financial results. Third quarter 2021 financial results will be available through the Investor Relations section of the company's website at https://irdirect.net/AUVI.

Applied UV to Host Third Quarter 2021 Conference Call on November 16th

The following replaces and corrects the release issued on October 19, 2021: Candida Auris is a pathogenic disease commonly acquired in hospitals or long-term care facilities Centers for Disease Control and Prevention ("CDC") has stated that 30-60% of people with C. auris bloodstream infections die CDC currently considers Candidiasis as one of the most significant infectious diseases in the world today.

CORRECTION: Applied UV's Systems Proven to Kill Candida Auris, an Emerging Multi-Drug-Resistant Fungus

Applied UV Inc's (NASDAQ: AUVI) wholly-owned subsidiary, SteriLumen Inc, has acquired  substantially all the assets of privately-held Scientific Air Management of Pompano Beach, Florida. The deal value includes $9.5 million in cash, 200,000 common shares of Applied UV stock, and an additional 200,000 common shares on achieving specific financial performance metrics.

Applied UV Acquires Scientific Air To Strengthen Infection Prevention Product Portfolio

Company's annualized revenues and be immediately accretive to Applied UV's earnings per share Continues the acquisition strategy by Applied UV to acquire and consolidate air and pathogen disinfection industry Company expects to be EBITDA positive during Q1 2022 Product portfolio includes patented 24/7 large air volume, whole room UV-C pathogen killing technology Distribution for North America with one of the largest distributors of healthcare supplies which supports accelerated adoption and top-line growth Since 2015, Scientific Air and its predecessor has been making air safer in hundreds of hospitals nationwide with no harmful byproducts Substantially deepens Applied UV's infection prevention product portfolio with mobile application and expands platform for growth Execution of management's two pronged top and bottom-line strategy: support organic growth of products with immediately accretive and innovative inorganic growth open up North America market for all our pathogen destroying products while expanding the international portfolio Applied UV to host investor call at 9:00 am EDT on October 14, 2021 MOUNT VERNON, NY / ACCESSWIRE / October 14, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced it has closed on the acquisition by its wholly-owned subsidiary, SteriLumen, Inc. ("SteriLumen"), of substantially all of the assets of privately-held Scientific Air Management ("Scientific Air"), of Pompano Beach, Florida. With the acquisition of the Scientific Air business, a recognized leader in its segment, Applied UV takes a significant step in transforming its business into a global healthcare infection control provider.

Applied UV Announces Strategic Acquisition of Scientific Air Management to Accelerate its Growth and Strengthen its Portfolio of High Growth Air Purification Technologies

Exclusive distributor has recently installed Airocide® units to help protect winemaking operations MOUNT VERNON, NY / ACCESSWIRE / October 4, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that its exclusive distributor for Mexico and Latin America , JARO Trading and Supply, has recently installed Airocide® units at wineries in Mexico, to help control mold and microorganisms in winemaking areas and reduce pathogen spread to create a safer and cleaner environment for staff and visitors. "The Airocide technology is already well established within the wine industry in North America and Europe.

Applied UV Continues Successful International Expansion with Installations of Airocide(R) Systems at Multiple Wineries in Mexico

MOUNT VERNON, NY / ACCESSWIRE / September 30, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced testing results from an independent third-party laboratory confirming that the SteriLumen's Airocide® HD Air Purification System, Applied UV's proprietary airborne pathogen killing technology that uses a patented combination of UVC and a proprietary, titanium dioxide based photocatalyst, kills SARS-CoV-2 (COVID-19 Virus). The study was designed to determine the Airocide® systems effectiveness at removing aerosolized SARS-CoV-2 virus from the air.

Applied UV Announces Laboratory Results Confirm SteriLumen's Airocide(R) Kills SARS-CoV-2 (COVID-19 Virus)

The stock price of Applied UV Inc (NASDAQ: AUVI) increased by over 22% during intraday trading today. This is why it happened.

AUVI Stock: Why It Increased Today

Applied UV Inc's (NASDAQ:AUVI) subsidiary, SteriLumen Inc,  has closed the acquisition of substantially all the assets of privately-held KES Science & Technology Inc (KES) and JJS Technologies LLC for $4.3 million in cash and 300,000 shares of its common stock. Applied UV expects the deals to bolster its presence in markets including food distribution, cannabis and post-harvest, wineries, and retail sectors.

Applied UV Shares Soar After Acquiring Assets Of KES Science & Technology

Transaction significantly scales air purification product portfolio and customer base Developed for NASA as a patented pathogen killing technology; patents were originally obtained by KES Expands access to food distribution, grocery chains, and fast-growing cannabis market Proprietary photocatalytic oxidation process thoroughly destroys viruses (including COVID-19), bacteria, spores, and fungi Accelerates the strategy to grow revenues through complimentary and synergistic acquisitions KES is expected to contribute significantly to revenues in 2022 and be immediately accretive to Applied UV's earnings per share Applied UV to host investor call at 9:00 am EDT on September 29, 2021 MOUNT VERNON, NY / ACCESSWIRE / September 29, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced it has closed on the acquisition by its wholly-owned subsidiary, SteriLumen, Inc. ("SteriLumen"), of substantially all of the assets of privately-held KES Science & Technology, Inc. ("KES") and JJS Technologies, LLC ("JJS"), each of Kennesaw, Georgia, including all of the rights to manufacture and sell all of its patented, air disinfection and purification technologies, for $4.3 million in cash and 300,000 common shares of Applied UV stock. Neither SteriLumen nor Applied UV will assume any long-term debt or non-operating liabilities of KES.

Applied UV Announces Acquisition of the Assets of KES Science & Technology

Installations in nearly 100 school dedicated observation rooms Airocide® technology helps schools reopen safely and allow for the safe return to campus MOUNT VERNON, NY / ACCESSWIRE / September 13, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that its Southeast Asia distributor has installed Airocide® units in nearly 100 schools that have created designated observation rooms where students are required to stay for a certain period prior to seeing a school nurse. With more than 18,000 K-12 facilities and close to 350 universities in South Korea, Applied UV expects that these installations will serve as a platform for the expansion of the Airocide® solution into additional areas located with school facilities to include nurses' rooms, cafeterias, kitchens, and classrooms at a time when face-to-face classes are fully allowed.

Applied UV Continues International Expansion with Airocide(R) Installation in South Korean Schools

MOUNT VERNON, NY / ACCESSWIRE / September 10, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that Q Saeed, CEO of Applied UV, will present at the virtual H.C. Wainwright Global Investor Conference.

Applied UV to Present at the Virtual H.C. Wainwright Global Investor Conference

Son Tay Hospital and the National Institute of Food Control to install Airocide® technology to protect patients, visitors and staff MOUNT VERNON, NY / ACCESSWIRE / September 8, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that its Vietnam distributor will be installing Airocide® units in Son Tay Hospital in Hanoi, and in the National Institute of Food Control, a leader in the field of testing, inspection, and certification of food products, to help create safer and cleaner environments for patients, visitors and staff. Applied UV continues to enhance its distributor relationships throughout Southeast Asia to meet the demand for its air and surface infection control products.

Applied UV Continues Global Expansion with Airocide(R) Installations in Vietnam

Applied UV, Inc. (AUVI) CEO Keyo Saeed on Q2 2021 Results - Earnings Call Transcript

Applied UV Inc (NASDAQ: AUVI) reported second-quarter sales growth of 11.1% year-over-year to $1.88 million, missing the consensus of $2.55 million. The company said it faced customer shipment delays during the quarter due to supply chain and logistics constraints.

Applied UV Shares Drop On Missing Q2 Estimates

Accelerated global commercial strategy for infection control products via partnerships and distribution Airocide® air purifications installations in hospitals, museums, wineries, and school systems Independent lab results confirmed SteriLumen's Lumicide™Ribbon kills SARS-CoV-2 (COVID-19 Virus) Hotel & hospitality demand for MunnWorks subsidiary recovering Continued focus on inorganic growth strategy via synergistic acquisitions Strengthened balance sheet with non-convertible Series A Cumulative Perpetual Preferred Stock offering raising gross proceeds of $13.8 million MOUNT VERNON, NY / ACCESSWIRE / August 17, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced its financial results for the second quarter of 2021. Q Saeed, Chief Executive Officer, stated, "Our second-quarter performance closes out a solid start to the first half of the fiscal year.

Applied UV Reports Second Quarter 2021 Results

Since 2020, over 100 Airocide® units installed to help critical U.S military facility remain open and protect staff and visitors MOUNT VERNON, NY / ACCESSWIRE / August 12, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that its U.S. distributor, BATTA Environmental Associates ("BATTA"), has installed additional Airocide® units at the U.S Army's Aberdeen Proving Ground ("APG") facility in Maryland, to help create safer and cleaner environment for staff and visitors. Since 2020, BATTA has installed over one hundred (100) Airocide systems throughout the APG facility.

Applied UV Continues Successful Installation of Airocide(R) Systems at U.S. Army's Aberdeen Proving Ground

Hungary's leading wine technology company, Cellarius, has recently installed additional Airocide® units to help wineries remain open and protect staff, visitors, and winemaking operations MOUNT VERNON, NY / ACCESSWIRE / August 10, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that its distributor, Cellarius, has recently installed additional Airocide® units at wineries in Greece and Hungary, to help control mold and microorganisms in winemaking areas and reduce pathogen spread to create safer and cleaner environment for staff and visitors. Airocide® units were not only installed in the winemaking area, but also in offices, visitor centers, and tasting rooms, bringing the total number of Airocide units installed in the two wineries to nearly 100.

News for Applied UV Stock (AUVI)